These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 28000905)
1. Teratomas produced from human pluripotent stem cells xenografted into immunodeficient mice - a histopathology atlas. Damjanov I; Andrews PW Int J Dev Biol; 2016; 60(10-11-12):337-419. PubMed ID: 28000905 [TBL] [Abstract][Full Text] [Related]
3. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues. Ulbright TM Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467 [TBL] [Abstract][Full Text] [Related]
4. Teratoma formation of human embryonic stem cells in three-dimensional perfusion culture bioreactors. Stachelscheid H; Wulf-Goldenberg A; Eckert K; Jensen J; Edsbagge J; Björquist P; Rivero M; Strehl R; Jozefczuk J; Prigione A; Adjaye J; Urbaniak T; Bussmann P; Zeilinger K; Gerlach JC J Tissue Eng Regen Med; 2013 Sep; 7(9):729-41. PubMed ID: 22438087 [TBL] [Abstract][Full Text] [Related]
5. Derivation of pluripotent stem cells from nascent undifferentiated teratoma. An Y; Sekinaka T; Tando Y; Okamura D; Tanaka K; Ito-Matsuoka Y; Takehara A; Yaegashi N; Matsui Y Dev Biol; 2019 Feb; 446(1):43-55. PubMed ID: 30529251 [TBL] [Abstract][Full Text] [Related]
6. Teratoma Assay for Testing Pluripotency and Malignancy of Stem Cells: Insufficient Reporting and Uptake of Animal-Free Methods-A Systematic Review. Montilla-Rojo J; Bialecka M; Wever KE; Mummery CL; Looijenga LHJ; Roelen BAJ; Salvatori DCF Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835305 [TBL] [Abstract][Full Text] [Related]
7. Isolation of human embryonic stem cell-derived teratomas for the assessment of pluripotency. Gertow K; Przyborski S; Loring JF; Auerbach JM; Epifano O; Otonkoski T; Damjanov I; Ahrlund-Richter L Curr Protoc Stem Cell Biol; 2007 Oct; Chapter 1():Unit1B.4. PubMed ID: 18785162 [TBL] [Abstract][Full Text] [Related]
8. Teratoma Formation Assay for Assessing Pluripotency and Tumorigenicity of Pluripotent Stem Cells. Miyawaki S; Okada Y; Okano H; Miura K Bio Protoc; 2017 Aug; 7(16):e2518. PubMed ID: 34541178 [TBL] [Abstract][Full Text] [Related]
9. Isolation of pluripotent neural crest-derived stem cells from adult human tissues by connexin-43 enrichment. Pelaez D; Huang CY; Cheung HS Stem Cells Dev; 2013 Nov; 22(21):2906-14. PubMed ID: 23750535 [TBL] [Abstract][Full Text] [Related]
10. The teratoma assay: an in vivo assessment of pluripotency. Wesselschmidt RL Methods Mol Biol; 2011; 767():231-41. PubMed ID: 21822879 [TBL] [Abstract][Full Text] [Related]
11. Differentiation-Defective Human Induced Pluripotent Stem Cells Reveal Strengths and Limitations of the Teratoma Assay and In Vitro Pluripotency Assays. Bouma MJ; van Iterson M; Janssen B; Mummery CL; Salvatori DCF; Freund C Stem Cell Reports; 2017 May; 8(5):1340-1353. PubMed ID: 28494940 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of pluripotent stem cell-derived teratoma formation by small molecules. Lee MO; Moon SH; Jeong HC; Yi JY; Lee TH; Shim SH; Rhee YH; Lee SH; Oh SJ; Lee MY; Han MJ; Cho YS; Chung HM; Kim KS; Cha HJ Proc Natl Acad Sci U S A; 2013 Aug; 110(35):E3281-90. PubMed ID: 23918355 [TBL] [Abstract][Full Text] [Related]
14. Teratoma: from spontaneous tumors to the pluripotency/malignancy assay. Bulic-Jakus F; Katusic Bojanac A; Juric-Lekic G; Vlahovic M; Sincic N Wiley Interdiscip Rev Dev Biol; 2016; 5(2):186-209. PubMed ID: 26698368 [TBL] [Abstract][Full Text] [Related]
15. Derivation of induced pluripotent stem cells from pig somatic cells. Ezashi T; Telugu BP; Alexenko AP; Sachdev S; Sinha S; Roberts RM Proc Natl Acad Sci U S A; 2009 Jul; 106(27):10993-8. PubMed ID: 19541600 [TBL] [Abstract][Full Text] [Related]
16. Teratoma formation in immunocompetent mice after syngeneic and allogeneic implantation of germline capable mouse embryonic stem cells. Aldahmash A; Atteya M; Elsafadi M; Al-Nbaheen M; Al-Mubarak HA; Vishnubalaji R; Al-Roalle A; Al-Harbi S; Manikandan M; Matthaei KI; Mahmood A Asian Pac J Cancer Prev; 2013; 14(10):5705-11. PubMed ID: 24289566 [TBL] [Abstract][Full Text] [Related]
17. Teratoma formation by human embryonic stem cells: evaluation of essential parameters for future safety studies. Hentze H; Soong PL; Wang ST; Phillips BW; Putti TC; Dunn NR Stem Cell Res; 2009 May; 2(3):198-210. PubMed ID: 19393593 [TBL] [Abstract][Full Text] [Related]
18. Testicular teratomas: an intersection of pluripotency, differentiation and cancer biology. Bustamante-Marín X; Garness JA; Capel B Int J Dev Biol; 2013; 57(2-4):201-10. PubMed ID: 23784831 [TBL] [Abstract][Full Text] [Related]
19. Functional in vivo and in vitro effects of 20q11.21 genetic aberrations on hPSC differentiation. Jo HY; Lee Y; Ahn H; Han HJ; Kwon A; Kim BY; Ha HY; Kim SC; Kim JH; Kim YO; Kim S; Koo SK; Park MH Sci Rep; 2020 Oct; 10(1):18582. PubMed ID: 33122739 [TBL] [Abstract][Full Text] [Related]
20. Derivation and characterization of two genetically unique human embryonic stem cell lines on in-house-derived human feeders. Kumar N; Hinduja I; Nagvenkar P; Pillai L; Zaveri K; Mukadam L; Telang J; Desai S; Mangoli V; Mangoli R; Padgaonkar S; Kaur G; Puri C; Bhartiya D Stem Cells Dev; 2009 Apr; 18(3):435-45. PubMed ID: 18699724 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]